Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Miromatrix Medical files $200M mixed securities shelf  16:16
07/01/22
07/01
16:16
07/01/22
16:16
MIRO

Miromatrix Medical

$3.27 /

-0.64 (-16.37%)

 
ShowHide Related Items >><<
MIRO Miromatrix Medical
$3.27 /

-0.64 (-16.37%)

MIRO Miromatrix Medical
$3.27 /

-0.64 (-16.37%)

07/19/21 Craig-Hallum
Craig-Hallum bullish on Miromatrix Medical, initiates with a Buy
07/19/21 Craig-Hallum
Miromatrix Medical initiated with a Buy at Craig-Hallum
MIRO Miromatrix Medical
$3.27 /

-0.64 (-16.37%)

Syndicate
iSpecimen files $100M mixed securities shelf  16:09
07/01/22
07/01
16:09
07/01/22
16:09
ISPC

iSpecimen

$2.25 /

+0.11 (+5.14%)

 
ShowHide Related Items >><<
ISPC iSpecimen
$2.25 /

+0.11 (+5.14%)

ISPC iSpecimen
$2.25 /

+0.11 (+5.14%)

01/04/22 Craig-Hallum
Craig-Hallum bullish on iSpecimen, initiates with a Buy
01/04/22 Craig-Hallum
iSpecimen initiated with a Buy at Craig-Hallum
ISPC iSpecimen
$2.25 /

+0.11 (+5.14%)

Syndicate
Agile Therapeutics prices upsized 26.7M share offering at 90c per share » 09:32
07/01/22
07/01
09:32
07/01/22
09:32
AGRX

Agile Therapeutics

$1.17 /

-0.38 (-24.60%)

Agile Therapeutics…

Agile Therapeutics announced the pricing of its upsized public offering of an aggregate of 26,666,666 shares of its common stock together with accompanying common stock warrants, at a public offering price of $0.90 per share and accompanying warrants. Each share of common stock was sold in the offering together with a Series A-1 warrant to purchase one share of common stock at an exercise price of $0.90 per share and a Series A-2 warrant to purchase one share of common stock at an exercise price of $0.90 per share. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. Offering was upsized to $24M from $20M.

ShowHide Related Items >><<
AGRX Agile Therapeutics
$1.17 /

-0.38 (-24.60%)

AGRX Agile Therapeutics
$1.17 /

-0.38 (-24.60%)

04/08/22 Maxim
Agile Therapeutics downgraded to Hold from Buy at Maxim
04/08/22 Maxim
Agile Therapeutics downgraded to Hold from Buy at Maxim
11/03/21 H.C. Wainwright
Agile Therapeutics price target lowered to $2.50 from $3.50 at H.C. Wainwright
09/13/21 H.C. Wainwright
Agile Therapeutics price target lowered to $3.50 from $7 at H.C. Wainwright
AGRX Agile Therapeutics
$1.17 /

-0.38 (-24.60%)

  • 08
    Oct
On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:29
07/01/22
07/01
09:29
07/01/22
09:29
MU

Micron

$55.36 /

-0.69 (-1.23%)

, FDX

FedEx

$226.84 /

-6.975 (-2.98%)

, CPNG

Coupang

$12.75 /

-0.22 (-1.70%)

, HOG

Harley-Davidson

$31.72 /

+0.24 (+0.76%)

, TTE

TotalEnergies

$52.98 /

-0.03 (-0.06%)

, BP

BP

$28.36 /

-0.395 (-1.37%)

, FRC

First Republic

$144.34 /

-1.42 (-0.97%)

, STR

Sitio Royalties

$23.14 /

-0.17 (-0.73%)

, GRNNF

Grand City Properties

$12.56 /

-2.34 (-15.70%)

, DCT

Duck Creek Technologies

$14.79 /

-3.64 (-19.75%)

, XPEV

XPeng

$31.77 /

-0.4101 (-1.27%)

, NMTR

9 Meters Biopharma

/

+

, CMCSA

Comcast

$39.24 /

-0.08 (-0.20%)

, PARA

Paramount

$24.68 /

-0.41 (-1.63%)

, VECT

Vectivbio

$5.50 /

-0.36 (-6.14%)

, SOUN

SoundHound

$2.68 /

-0.045 (-1.65%)

, SYM

Symbotic

$10.99 /

-0.875 (-7.37%)

, WMT

Walmart

$121.47 /

-0.43 (-0.35%)

Institutional investors…

ShowHide Related Items >><<
XPEV XPeng
$31.77 /

-0.4101 (-1.27%)

WMT Walmart
$121.47 /

-0.43 (-0.35%)

VECT Vectivbio
$5.50 /

-0.36 (-6.14%)

TTE TotalEnergies
$52.98 /

-0.03 (-0.06%)

SYM Symbotic
$10.99 /

-0.875 (-7.37%)

STR Sitio Royalties
$23.14 /

-0.17 (-0.73%)

SOUN SoundHound
$2.68 /

-0.045 (-1.65%)

PARA Paramount
$24.68 /

-0.41 (-1.63%)

NMTR 9 Meters Biopharma
/

+

MU Micron
$55.36 /

-0.69 (-1.23%)

HOG Harley-Davidson
$31.72 /

+0.24 (+0.76%)

FRC First Republic
$144.34 /

-1.42 (-0.97%)

FDX FedEx
$226.84 /

-6.975 (-2.98%)

DCT Duck Creek Technologies
$14.79 /

-3.64 (-19.75%)

CPNG Coupang
$12.75 /

-0.22 (-1.70%)

CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

BP BP
$28.36 /

-0.395 (-1.37%)

MU Micron
$55.36 /

-0.69 (-1.23%)

07/01/22 Evercore ISI
Evercore reiterates Outperform rating on Micron, sees EPS bottoming in February
07/01/22 Citi
Micron price target lowered to $80 from $85 at Citi
07/01/22 Cowen
Micron price target lowered to $70 from $90 at Cowen
07/01/22 Baird
Micron price target lowered to $60 from $90 at Baird
FDX FedEx
$226.84 /

-6.975 (-2.98%)

07/01/22 Berenberg
FedEx downgraded to Hold from Buy at Berenberg
06/30/22 BofA
FedEx price target raised to $287 from $276 at BofA
06/30/22 KeyBanc
FedEx price target raised to $325 from $300 at KeyBanc
06/30/22 BMO Capital
FedEx price target raised to $280 from $270 at BMO Capital
CPNG Coupang
$12.75 /

-0.22 (-1.70%)

06/30/22 Credit Suisse
Coupang upgraded to Outperform at Credit Suisse following underperformance
06/30/22 Credit Suisse
Coupang upgraded to Outperform from Neutral at Credit Suisse
06/29/22 Morgan Stanley
Coupang initiated with an Overweight at Morgan Stanley
05/12/22 Mizuho
Coupang price target lowered to $18 from $28 at Mizuho
HOG Harley-Davidson
$31.72 /

+0.24 (+0.76%)

06/30/22 DA Davidson
Harley-Davidson initiated with a Neutral at DA Davidson
05/24/22 BofA
BofA cuts Harley-Davidson production estimate
05/20/22 William Blair
Harley-Davidson estimates cut on production shutdown at William Blair
04/28/22 BMO Capital
Harley-Davidson price target lowered to $57 from $62 at BMO Capital
TTE TotalEnergies
$52.98 /

-0.03 (-0.06%)

07/01/22 Jefferies
TotalEnergies upgraded to Buy from Hold at Jefferies
06/29/22 Bernstein
TotalEnergies upgraded to Outperform from Market Perform at Bernstein
06/09/22 Credit Suisse
TotalEnergies initiated with an Outperform at Credit Suisse
05/13/22 Berenberg
TotalEnergies upgraded to Buy from Hold at Berenberg
BP BP
$28.36 /

-0.395 (-1.37%)

06/09/22 Credit Suisse
BP initiated with a Neutral at Credit Suisse
06/09/22 Credit Suisse
BP initiated with a Neutral at Credit Suisse
05/11/22 Morgan Stanley
BP price target raised to 540 GBp from 490 GBp at Morgan Stanley
FRC First Republic
$144.34 /

-1.42 (-0.97%)

07/01/22 JPMorgan
First Republic price target lowered to $200 from $215 at JPMorgan
07/01/22 Atlantic Equities
Atlantic ups First Republic after studying last Fed rate-tightening cycle
07/01/22 Atlantic Equities
First Republic upgraded to Overweight from Neutral at Atlantic Equities
05/26/22 Wolfe Research
First Republic price target lowered to $157 from $194 at Wolfe Research
STR Sitio Royalties
$23.14 /

-0.17 (-0.73%)

07/01/22 RBC Capital
Sitio Royalties upgraded to Outperform from Sector Perform at RBC Capital
06/15/22 Credit Suisse
Credit Suisse upgrades Sitio to Outperform, names new Top Pick in royalties
06/15/22 Credit Suisse
Sitio Royalties upgraded to Outperform from Neutral at Credit Suisse
GRNNF Grand City Properties
$12.56 /

-2.34 (-15.70%)

07/01/22 HSBC
Grand City Properties upgraded to Buy from Hold at HSBC
06/17/22 Societe Generale
Grand City Properties upgraded to Buy from Hold at Societe Generale
04/04/22 Barclays
Grand City Properties downgraded to Underweight from Equal Weight at Barclays
03/30/22 JPMorgan
Grand City Properties downgraded to Neutral from Overweight at JPMorgan
DCT Duck Creek Technologies
$14.79 /

-3.64 (-19.75%)

07/01/22 JMP Securities
Duck Creek downgraded to Market Perform from Outperform at JMP Securities
06/30/22 BofA
Duck Creek Technologies downgraded to Neutral from Buy at BofA
06/30/22 BofA
Duck Creek Technologies downgraded to Neutral from Buy at BofA
06/30/22 RBC Capital
Duck Creek Technologies price target lowered to $18 from $25 at RBC Capital
XPEV XPeng
$31.77 /

-0.4101 (-1.27%)

07/01/22 Nomura
XPeng downgraded to Neutral on short-term cash burn at Nomura
06/30/22 Nomura
XPeng downgraded to Neutral from Buy at Nomura
06/21/22 Citi
XPeng price target raised to $51.59 from $36.70 at Citi
05/24/22 JPMorgan
XPeng price target lowered to $35 from $42 at JPMorgan
NMTR 9 Meters Biopharma
/

+

07/01/22 Maxim
9 Meters Biopharma downgraded to Hold from Buy at Maxim
06/22/22 Truist
9 Meters Biopharma price target lowered to $2 from $5 at Truist
06/22/22 BMO Capital
9 Meters Biopharma price target lowered to $3 from $5 at BMO Capital
07/08/21 BMO Capital
9 Meters Biopharma initiated with an Outperform at BMO Capital
CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

07/01/22 Daiwa
Comcast initiated with an Outperform at Daiwa
06/29/22 TD Securities
Comcast price target lowered to $60 from $65 at TD Securities
06/28/22 Scotiabank
Comcast assumed with an Outperform at Scotiabank (yesterday)
06/21/22 Truist
Magnite well positioned to partner with Netflix, says Truist
PARA Paramount
$24.68 /

-0.41 (-1.63%)

07/01/22 Daiwa
Paramount initiated with a Neutral at Daiwa
06/15/22 Evercore ISI
Disney showing good financial discipline with IPL renewal, says Evercore ISI
06/02/22 Wolfe Research
Paramount assumed at Underperform from Outperform at Wolfe Research
05/23/22 Citi
Paramount price target lowered to $44 from $47 at Citi
VECT Vectivbio
$5.50 /

-0.36 (-6.14%)

07/01/22 Piper Sandler
Vectivbio initiated with an Overweight at Piper Sandler
SOUN SoundHound
$2.68 /

-0.045 (-1.65%)

07/01/22 Cantor Fitzgerald
SoundHound initiated with a Neutral at Cantor Fitzgerald
06/28/22 Wedbush
Wedbush bullish on SoundHound, initiates with an Outperform
06/28/22 Wedbush
SoundHound initiated with an Outperform at Wedbush
05/18/22 Northland
SoundHound replacing Cerence at Hyundai, says Northland
SYM Symbotic
$10.99 /

-0.875 (-7.37%)

07/01/22 Citi
Symbotic initiated with a Buy at Citi
06/23/22 Deutsche Bank
Symbotic initiated with a Buy at Deutsche Bank
06/23/22 Baird
Symbotic initiated with an Outperform at Baird
06/21/22 Cowen
Symbotic initiated with an Outperform at Cowen
WMT Walmart
$121.47 /

-0.43 (-0.35%)

06/27/22 Goldman Sachs
Walmart price target lowered to $138 from $160 at Goldman Sachs
06/17/22 Truist
Deal with Walmart an 'incremental positive' for Roku, says Truist
XPEV XPeng
$31.77 /

-0.4101 (-1.27%)

WMT Walmart
$121.47 /

-0.43 (-0.35%)

VECT Vectivbio
$5.50 /

-0.36 (-6.14%)

PARA Paramount
$24.68 /

-0.41 (-1.63%)

NMTR 9 Meters Biopharma
/

+

MU Micron
$55.36 /

-0.69 (-1.23%)

HOG Harley-Davidson
$31.72 /

+0.24 (+0.76%)

FRC First Republic
$144.34 /

-1.42 (-0.97%)

FDX FedEx
$226.84 /

-6.975 (-2.98%)

DCT Duck Creek Technologies
$14.79 /

-3.64 (-19.75%)

CPNG Coupang
$12.75 /

-0.22 (-1.70%)

CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

BP BP
$28.36 /

-0.395 (-1.37%)

  • 15
    Jun
  • 14
    Sep
  • 10
    Aug
XPEV XPeng
$31.77 /

-0.4101 (-1.27%)

WMT Walmart
$121.47 /

-0.43 (-0.35%)

TTE TotalEnergies
$52.98 /

-0.03 (-0.06%)

PARA Paramount
$24.68 /

-0.41 (-1.63%)

MU Micron
$55.36 /

-0.69 (-1.23%)

HOG Harley-Davidson
$31.72 /

+0.24 (+0.76%)

FDX FedEx
$226.84 /

-6.975 (-2.98%)

CPNG Coupang
$12.75 /

-0.22 (-1.70%)

CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

BP BP
$28.36 /

-0.395 (-1.37%)

XPEV XPeng
$31.77 /

-0.4101 (-1.27%)

WMT Walmart
$121.47 /

-0.43 (-0.35%)

VECT Vectivbio
$5.50 /

-0.36 (-6.14%)

TTE TotalEnergies
$52.98 /

-0.03 (-0.06%)

SYM Symbotic
$10.99 /

-0.875 (-7.37%)

SOUN SoundHound
$2.68 /

-0.045 (-1.65%)

PARA Paramount
$24.68 /

-0.41 (-1.63%)

MU Micron
$55.36 /

-0.69 (-1.23%)

HOG Harley-Davidson
$31.72 /

+0.24 (+0.76%)

FRC First Republic
$144.34 /

-1.42 (-0.97%)

FDX FedEx
$226.84 /

-6.975 (-2.98%)

DCT Duck Creek Technologies
$14.79 /

-3.64 (-19.75%)

CPNG Coupang
$12.75 /

-0.22 (-1.70%)

CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

BP BP
$28.36 /

-0.395 (-1.37%)

XPEV XPeng
$31.77 /

-0.4101 (-1.27%)

WMT Walmart
$121.47 /

-0.43 (-0.35%)

SYM Symbotic
$10.99 /

-0.875 (-7.37%)

STR Sitio Royalties
$23.14 /

-0.17 (-0.73%)

SOUN SoundHound
$2.68 /

-0.045 (-1.65%)

PARA Paramount
$24.68 /

-0.41 (-1.63%)

MU Micron
$55.36 /

-0.69 (-1.23%)

HOG Harley-Davidson
$31.72 /

+0.24 (+0.76%)

FDX FedEx
$226.84 /

-6.975 (-2.98%)

DCT Duck Creek Technologies
$14.79 /

-3.64 (-19.75%)

CPNG Coupang
$12.75 /

-0.22 (-1.70%)

CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

BP BP
$28.36 /

-0.395 (-1.37%)

Options
Largest borrow rate increases among liquid names » 08:45
07/01/22
07/01
08:45
07/01/22
08:45
BYND

Beyond Meat

$23.91 /

-0.44 (-1.81%)

, CSSE

Chicken Soup for the Soul

$7.37 /

+0.17 (+2.36%)

, SJT

San Juan Basin Royalty Trust

$8.68 /

-0.76 (-8.05%)

, BKKT

Bakkt

$2.10 /

-0.03 (-1.41%)

, NNOX

Nano-X Imaging

$11.30 /

-0.11 (-0.96%)

, APPH

AppHarvest

$3.48 /

-0.025 (-0.71%)

, GNUS

Genius Brands

/

+

, NKLA

Nikola

$4.77 /

+0.05 (+1.06%)

, MDT

Medtronic

$89.80 /

-0.64 (-0.71%)

, PMVP

PMV Pharmaceuticals

$14.27 /

+0.38 (+2.74%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Beyond Meat (BYND) 77.64% +34.48, Chicken Soup for the Soul Entertainment (CSSE) 68.01% +3.10, San Juan Basin Royalty Trust (SJT) 12.66% +2.53, Bakkt Holdings (BKKT) 30.42% +2.10, Nano X Imaging (NNOX) 35.12% +1.11, AppHarvest (APPH) 73.61% +0.87, Genius Brands (GNUS) 36.96% +0.82, Nikola (NKLA) 13.30% +0.60, Medtronic (MDT) 0.73% +0.48, and PMV Pharmaceuticals (PMVP) 1.10% +0.43.

ShowHide Related Items >><<
PMVP PMV Pharmaceuticals
$14.27 /

+0.38 (+2.74%)

NNOX Nano-X Imaging
$11.30 /

-0.11 (-0.96%)

NKLA Nikola
$4.77 /

+0.05 (+1.06%)

MDT Medtronic
$89.80 /

-0.64 (-0.71%)

GNUS Genius Brands
/

+

CSSE Chicken Soup for the Soul
$7.37 /

+0.17 (+2.36%)

BYND Beyond Meat
$23.91 /

-0.44 (-1.81%)

BKKT Bakkt
$2.10 /

-0.03 (-1.41%)

APPH AppHarvest
$3.48 /

-0.025 (-0.71%)

BYND Beyond Meat
$23.91 /

-0.44 (-1.81%)

06/07/22 Piper Sandler
Piper keeps $12 target on Beyond Meat despite early jerky success
05/12/22 BMO Capital
Beyond Meat price target lowered to $30 from $60 at BMO Capital
05/12/22 Cowen
Beyond Meat price target lowered to $26 from $42 at Cowen
05/12/22 Mizuho
Beyond Meat price target lowered to $21 from $35 at Mizuho
CSSE Chicken Soup for the Soul
$7.37 /

+0.17 (+2.36%)

06/14/22 DA Davidson
DA Davidson likes Chicken Soup for the Soul amid strong box office, Redbox deal
05/27/22 B. Riley
Redbox downgraded to Sell from Neutral at B. Riley
05/17/22 Guggenheim
Chicken Soup for the Soul resumed with a Buy at Guggenheim
05/13/22 B. Riley
Chicken Soup for the Soul price target lowered to $26 from $32 at B. Riley
SJT San Juan Basin Royalty Trust
$8.68 /

-0.76 (-8.05%)

BKKT Bakkt
$2.10 /

-0.03 (-1.41%)

01/12/22 Jefferies
Bakkt price target lowered to $7 from $13.50 at Jefferies
11/11/21
Fly Intel: Top five analyst initiations
11/11/21 Jefferies
Jefferies starts Bakkt at Hold as more adoption 'proof-points' awaited
11/11/21 Jefferies
Bakkt initiated with a Hold at Jefferies
NNOX Nano-X Imaging
$11.30 /

-0.11 (-0.96%)

APPH AppHarvest
$3.48 /

-0.025 (-0.71%)

02/22/22 Barclays
AppHarvest price target lowered to $5.50 from $13 at Barclays
08/25/21 Oppenheimer
AppHarvest initiated with an Outperform at Oppenheimer
08/12/21 Cowen
AppHarvest price target lowered to $14 from $32 at Cowen
GNUS Genius Brands
/

+

12/15/21
Genius Brands initiated with a Buy at Dawson James
NKLA Nikola
$4.77 /

+0.05 (+1.06%)

05/10/22 Wedbush
Nikola price target lowered to $10 from $15 at Wedbush
03/25/22 Wedbush
Nikola's analyst day sets bullish tone for 2022, beyond, says Wedbush
03/24/22 Deutsche Bank
Deutsche Bank left Nikola analyst day 'highly encouraged'
03/10/22 JPMorgan
Nikola is tracking to 2022 goals, says JPMorgan
MDT Medtronic
$89.80 /

-0.64 (-0.71%)

06/01/22 Atlantic Equities
Medtronic downgraded to Neutral from Overweight at Atlantic Equities
05/31/22 Raymond James
Medtronic price target lowered to $109 from $116 at Raymond James
05/31/22 Truist
Medtronic price target lowered to $111 from $121 at Truist
05/27/22 RBC Capital
Medtronic price target lowered to $122 from $135 at RBC Capital
PMVP PMV Pharmaceuticals
$14.27 /

+0.38 (+2.74%)

06/09/22 Oppenheimer
PMV Pharmaceuticals price target raised to $33 from $30 at Oppenheimer
06/06/22 H.C. Wainwright
Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
03/02/22 Oppenheimer
Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target
03/02/22 Oppenheimer
PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
PMVP PMV Pharmaceuticals
$14.27 /

+0.38 (+2.74%)

NNOX Nano-X Imaging
$11.30 /

-0.11 (-0.96%)

NKLA Nikola
$4.77 /

+0.05 (+1.06%)

MDT Medtronic
$89.80 /

-0.64 (-0.71%)

GNUS Genius Brands
/

+

CSSE Chicken Soup for the Soul
$7.37 /

+0.17 (+2.36%)

BYND Beyond Meat
$23.91 /

-0.44 (-1.81%)

BKKT Bakkt
$2.10 /

-0.03 (-1.41%)

APPH AppHarvest
$3.48 /

-0.025 (-0.71%)

  • 02
    Jul
PMVP PMV Pharmaceuticals
$14.27 /

+0.38 (+2.74%)

NKLA Nikola
$4.77 /

+0.05 (+1.06%)

MDT Medtronic
$89.80 /

-0.64 (-0.71%)

BYND Beyond Meat
$23.91 /

-0.44 (-1.81%)

PMVP PMV Pharmaceuticals
$14.27 /

+0.38 (+2.74%)

NNOX Nano-X Imaging
$11.30 /

-0.11 (-0.96%)

NKLA Nikola
$4.77 /

+0.05 (+1.06%)

MDT Medtronic
$89.80 /

-0.64 (-0.71%)

CSSE Chicken Soup for the Soul
$7.37 /

+0.17 (+2.36%)

BYND Beyond Meat
$23.91 /

-0.44 (-1.81%)

BKKT Bakkt
$2.10 /

-0.03 (-1.41%)

APPH AppHarvest
$3.48 /

-0.025 (-0.71%)

SJT San Juan Basin Royalty Trust
$8.68 /

-0.76 (-8.05%)

NNOX Nano-X Imaging
$11.30 /

-0.11 (-0.96%)

NKLA Nikola
$4.77 /

+0.05 (+1.06%)

MDT Medtronic
$89.80 /

-0.64 (-0.71%)

GNUS Genius Brands
/

+

BYND Beyond Meat
$23.91 /

-0.44 (-1.81%)

BKKT Bakkt
$2.10 /

-0.03 (-1.41%)

APPH AppHarvest
$3.48 /

-0.025 (-0.71%)

Downgrade
Neptune Wellness downgraded to Neutral from Buy at Alliance Global Partners » 08:32
07/01/22
07/01
08:32
07/01/22
08:32
NEPT

Neptune Wellness

$1.38 /

-0.08 (-5.48%)

Alliance Global Partners…

Alliance Global Partners analyst Aaron Grey downgraded Neptune Wellness Solutions to Neutral from Buy without a price target. The analyst had been looking for the company to secure some debt or credit to fund growth since the beginning of the year, but has not seen it to dote. Shareholders could be subject to further dilution if credit is not obtained or Neptune's cannabis assets are not sold, Grey tells investors in a research note. He says liquidity concerns "are too great at this time."

ShowHide Related Items >><<
NEPT Neptune Wellness
$1.38 /

-0.08 (-5.48%)

NEPT Neptune Wellness
$1.38 /

-0.08 (-5.48%)

11/17/21 Desjardins
Neptune Wellness price target lowered to C$0.75 from C$1.00 at Desjardins
08/16/21 Desjardins
Neptune Wellness price target lowered to C$1 from C$1.10 at Desjardins
07/20/21 Alliance Global Partners
Neptune Wellness price target lowered to C$1.50 from C$4
07/19/21
Fly Intel: Top five analyst downgrades
NEPT Neptune Wellness
$1.38 /

-0.08 (-5.48%)

Downgrade
9 Meters Biopharma downgraded to Hold from Buy at Maxim » 08:01
07/01/22
07/01
08:01
07/01/22
08:01
NMTR

9 Meters Biopharma

/

+

Maxim analyst Jason…

Maxim analyst Jason McCarthy downgraded 9 Meters Biopharma to Hold from Buy without a price target after the company announced the Phase 2 results from its vurolenatide VIBRANT study for short bowel syndrome as well as a senior secured convertible notes facility with a single lender for up to $70M. The initial drawdown of $20M may extend 9 Meters' cash runway into Q4 of 2023, but based on the terms of the convertible notes, there is likelihood of additional dilution, McCarthy tells investors in a research note.

ShowHide Related Items >><<
NMTR 9 Meters Biopharma
/

+

NMTR 9 Meters Biopharma
/

+

06/22/22 Truist
9 Meters Biopharma price target lowered to $2 from $5 at Truist
06/22/22 BMO Capital
9 Meters Biopharma price target lowered to $3 from $5 at BMO Capital
07/08/21 BMO Capital
9 Meters Biopharma initiated with an Outperform at BMO Capital
NMTR 9 Meters Biopharma
/

+

Thursday
Downgrade
Talaris Therapeutics downgraded to Market Perform at SVB Securities » 16:26
06/30/22
06/30
16:26
06/30/22
16:26
TALS

Talaris Therapeutics

$4.35 /

-2.65 (-37.86%)

SVB Securities analyst…

SVB Securities analyst Mani Foroohar downgraded Talaris Therapeutics to Market Perform from Outperform.

ShowHide Related Items >><<
TALS Talaris Therapeutics
$4.35 /

-2.65 (-37.86%)

Hot Stocks
Fate Therapeutics appoints Brian Powl Chief Commercial Officer » 16:04
06/30/22
06/30
16:04
06/30/22
16:04
FATE

Fate Therapeutics

$24.83 /

-0.04 (-0.16%)

Fate Therapeutics…

Fate Therapeutics announced that Brian T. Powl has been appointed Chief Commercial Officer. Mr. Powl brings to Fate Therapeutics extensive commercial leadership experience in hematologic malignancies and solid tumors, having previously served as the Global Commercial CAR T lead at Celgene Corporation where he oversaw the commercial development strategy of the company's CAR T-cell therapies.Mr. Powl most recently served as Senior Vice President, Commercial Development & Marketing at MEI Pharma, Inc., where he led the commercialization efforts of a late-stage small molecule program in B-cell malignancies across marketing, sales, market access and commercial operations. Prior to MEI Pharma, Mr. Powl was Vice President, Global Commercial CAR T lead at Celgene Corporation, where he oversaw a global portfolio of new cell therapy products, including the commercialization of the CD19- and BCMA-targeted CAR T-cell therapy programs. During his tenure at Celgene, Mr. Powl also held various senior level positions, including leading their flagship multiple myeloma franchise in which he led the marketing of Revlimid and Pomalyst as well as their global commercial operations group for oncology products outside the United States. Prior to Celgene, Mr. Powl held sales and marketing positions at Novartis Oncology and Centocor, Inc. Mr. Powl holds a BS in Biochemistry from the University of California, San Diego and an MBA in Healthcare

ShowHide Related Items >><<
FATE Fate Therapeutics
$24.83 /

-0.04 (-0.16%)

FATE Fate Therapeutics
$24.83 /

-0.04 (-0.16%)

06/03/22 Baird
Baird starts Fate Therapeutics at Neutral with limited data on NK cell therapies
06/02/22 Baird
Fate Therapeutics initiated with a Neutral at Baird
05/23/22 Piper Sandler
Fate Therapeutics price target lowered to $71 from $113 at Piper Sandler
04/26/22 Stifel
Nkarta's AML/NHL data 'a positive' for CAR-NK space, says Stifel
FATE Fate Therapeutics
$24.83 /

-0.04 (-0.16%)

FATE Fate Therapeutics
$24.83 /

-0.04 (-0.16%)

Hot Stocks
Titan Medical appoints Cary Vance as CEO » 16:03
06/30/22
06/30
16:03
06/30/22
16:03
TMDI

Titan Medical

/

+

Titan Medical announced…

Titan Medical announced that Cary Vance has been appointed as the company's president and CEO effective July 1. Vance will succeed Paul Cataford, Titan's chair of the board of directors, who has served as interim president and CEO since December 2021. Vance previously served as president and CEO at Xcath Incorporated, a privately held neurovascular robotics company.

ShowHide Related Items >><<
TMDI Titan Medical
/

+

TMDI Titan Medical
/

+

03/25/22 Oppenheimer
Titan Medical downgraded to Perform from Outperform at Oppenheimer
03/25/22 Oppenheimer
Titan Medical downgraded to Perform from Outperform at Oppenheimer
TMDI Titan Medical
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.